Well said muck. A little PR would be nice too. Here is one for ya...How about we see a PR on this Arqule?2016 Gastrointestinal Cancers Symposium January 21-23rd 2016. Arqule had 1 abstract. "Tumor and plasma biomarker analysis from the randomized controlled phase II trial (RCT) of tivantinib in second-line hepatocellular carcinoma (HCC)." Note the last line of the abstract. "IHC results on over 900 tumor samples analyzed in the ongoing METIV-HCC phase 3 study will also be presented." Only to be seen by the few that happen to see the poster or the presentation???? If I really wanted to I guess I could sign up for a guest account on ASCO site and listen to the presentation but don't really feel like giving them my info.